N/A N=2,579 PROMISE EBF: Safety and Efficacy of Exclusive Breastfeeding Promotion in the Era of HIV in Sub-Saharan Africa
Diarrhea
Primary: Exclusive Breastfeeding Rates in Burkina Faso — 310; 161 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=243 Prenatal Interventions to Promote Exclusive Breastfeeding
Breastfeeding · Intention · Health Behavior
Primary: Number of Participants Who Intended to Exclusively Breastfeed Post-intervention — 40; 36; 86; 67 Participants
N/A N=1,411 Comparison of Breast Feeding Counseling and Video Demonstration on Exclusive Breast Feeding Rates at 6 Weeks
Exclusive Breast Feeding
Primary: Exclusive Breast Feeding Rate at Six Weeks Postnatal Age — 271; 117; 97 Participants
N/A N=442 Home Based Peer Support Program for Mothers With Low Breastfeeding Self-efficacy
Breastfeeding
Primary: Infant Feeding Status: Exclusive Breastfeeding — 46; 39 Participants
Phase 4 N=285 BLIS - Breastfeeding Levonorgestrel IUD Study
Contraception
Primary: Breastfeeding Continuation Rates at 8 Weeks Postpartum — 88; 86 Participants
N/A N=1,296 Breast for Success: A Family-Centered Intervention in Support of Breastfeeding Among High-risk Low-income Mothers
Breastfeeding
Primary: Program Feasibility- Feeding Outcome Collected — 287; 288; 314 participants
N/A N=99 Breastfeeding Support Intervention in Jaundiced Infants
Jaundice · Breastfeeding
Primary: Number of Participants Exclusively Breastfeeding at 3 Months, or 3 Months Corrected if the Infant Was Born Prematurely — 22; 24 Participants — p=0.40
N/A N=168 BOOST: Breastfeeding Onset and Onward With Support Tools
Breastfeeding Duration
Primary: Number of Participants Breastfeeding Their Infants at 1 Month — 76; 74 Participants
Phase 4 N=150 Breastfeeding Etonogestrel Implant Study
Contraception
Primary: Number of Participants With Continuation of Breastfeeding at 8 Weeks Postpartum — 54; 45; 48; 43 Participants
N/A N=2,288 Alive & Thrive Evaluation in Burkina Faso
Breast Feeding · Breast Feeding, Exclusive
Primary: Exclusive Breastfeeding on the Day Preceding the Interview as Assessed by Cross Sectional Survey — 0.933; 0.512 percentage of exclusive breastfeeding
N/A N=280 PRenatal Video-Based Education and PostPARtum Effects
Breastfeeding
Primary: Breastfeeding Exclusivity — 67; 84 Participants — p=.1200
N/A N=124 Newborn Feeding and Infant Phenotype
Breast Feeding
Primary: Change in Total Adipose Tissue Volume — 0.718; 0.901; 0.775 Litres
N/A N=180 Early Initiation of Milk Expression in Mothers of Very Low Birth Weight Infants
Breast Milk Expression
Primary: Pumped Milk Volume Day 1 — 3; 4; 5 mL — p=0.015
N/A N=3,188 Low-birthweight Infant Feeding Exploration
Low Birthweight · Pre-Term
Primary: Length-for-Age Z-score — -1.43 Z-score
N/A N=41 Effect of Early Skin to Skin Contact on Breast Feeding Behaviour in Term Newborns: A Randomized Controlled Trial
Breastfeeding
Primary: The Median Breast Feeding Score — 8; 9 scores
Phase 4 N=35 Postpartum Levonorgestrel-releasing Intrauterine System and Breastfeeding
Postpartum Contraception
Primary: Breastfeeding — 10; 9 participants
N/A N=428 Evaluating a Coparenting Breastfeeding Support Intervention
Parenting · Breastfeeding
Primary: Exclusive Breastfeeding Rate at 12 Weeks Postpartum — 70; 63 percentage of participants — p=0.27
N/A N=53 Breastfeeding Support and Weight Management for Black Women
Breastfeeding · Weight Loss
Primary: Number of Participants Still Breastfeeding at 20 Weeks Postpartum — 9; 8 Participants
N/A N=250 Promoting Self-Management of Breast and Nipple Pain With Technology (PROMPT) for Breastfeeding Women Study
Breastfeeding, Exclusive · Pain, Acute · Maternal Distress
Primary: Visual Analogue Scale for Breast and Nipple Pain Severity — 39.43; 36.55; 44.31; 36.93 units on a scale — p=<0.0045
N/A N=155 Immediate Postpartum Contraceptive Implant Placement and Breastfeeding Success in Women at Risk for Low Milk Supply: A Non-inferiority Trial
Contraception · Breastfeeding · Postpartum Contraception
Primary: Number of Participants Breastfeeding at 6 Months — 6; 4; 6 Participants
N/A N=197 Breastfeeding and Oral Contraceptives: a Randomized, Controlled Trial
Breast Feeding · Contraception
Primary: Number of Participants Who Continued to Breastfeed at 6 Months — 15; 14; 8; 9 participants
N/A N=170 Impact of a Smartphone Application on Postpartum Weight Loss and Breastfeeding Rates Among Low-income, Urban Women
Breastfeeding
Primary: Number of Participants Breastfeeding Without Formula Supplementation — 30; 30 Participants
N/A N=46 Feasibility of a Touch Screen Computer Based Breast-feeding Educational Support Program
Pregnancy Related
Primary: Breastfeeding Assessment — 121.2; 120.3 days
N/A N=100 A Mobile-health Pilot Experiment Targeting Mothers With Newborns in Rural Areas of San Juan Sacatepequez, Guatemala
Exclusive Breastfeeding · Co-production of Health in Communities
Primary: Number of Participants With Changes in Knowledge — 12; 2; 11; 3 participants
N/A N=74 Prenatal Breast Pump Education of Mothers and Their Support Person
Preterm Birth · Breast Feeding
Primary: Onset of Lactogenesis Stage II Through Volume Attainment — 84.8; 81 hours — p=0.985
Phase 4 N=69 Early Versus Standard Postpartum Insertion of the Etonogestrel Contraceptive Implant
Complications; Contraceptive · Female Lactation
Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05
N/A N=94 Breast Versus Bottle Study
Breastfeeding · Bottle Feeding
Primary: Infant Intake During the Observed Feeding (mL) — 91.9; 87.6 mL — p=0.634
N/A N=14 A Study of Breastfeeding in Buprenorphine Maintained Women
Opioid Dependency
Primary: Maternal Plasma Concentrations of Buprenorphine — 1.2; 1.7; 2.0; 2.4 ug/mL
Phase 4 N=30 Progestin-Only Pill Use and Breastfeeding Study
Contraception · Breastfeeding
Primary: Exclusive Lactation Among Birthing People at 8 Weeks Postpartum. — 7; 7; 6 Participants
Phase 3 N=95 Labor and Delivery Implant Insertion: A Randomized Controlled Trial
Postpartum Contraception · Family Planning
Primary: Time to Lactogenesis Stage II [Questionnaire] — 65; 67.5 hours